Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
86.94 USD | +0.95% | +16.65% | +20.70% |
May. 08 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
May. 08 | Ligand Pharmaceuticals Shares Rise After Q1 Adjusted Earnings, Revenue Beat Views | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.70% | 1.55B | |
+31.02% | 695B | |
+26.51% | 568B | |
-4.68% | 361B | |
+19.55% | 330B | |
+4.05% | 283B | |
+16.70% | 239B | |
+8.78% | 204B | |
-7.93% | 198B | |
+8.11% | 168B |
- Stock Market
- Equities
- LGND Stock
- News Ligand Pharmaceuticals Incorporated
- Ligand Pharmaceuticals Incorporated : Roth Capital Adjusts Price Target on Ligand Pharmaceuticals to $200 From $195, Maintains Buy Rating